RGBP
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Jul 2 closing price
Capitalization
1.13M
SHJBF
Price
$1.97
Change
+$0.73 (+58.87%)
Updated
Dec 31 closing price
Capitalization
4.5B
Interact to see
Advertisement

RGBP vs SHJBF

Header iconRGBP vs SHJBF Comparison
Open Charts RGBP vs SHJBFBanner chart's image
Regen Biopharma
Price$0.05
Change-$0.00 (-0.00%)
Volume$5.23K
Capitalization1.13M
SHANGHAI JUNSHI BIOSCIENCES
Price$1.97
Change+$0.73 (+58.87%)
Volume$150
Capitalization4.5B
RGBP vs SHJBF Comparison Chart in %
Loading...
RGBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RGBP vs. SHJBF commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGBP is a Hold and SHJBF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (RGBP: $0.05 vs. SHJBF: $1.97)
Brand notoriety: RGBP and SHJBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RGBP: 31% vs. SHJBF: 100%
Market capitalization -- RGBP: $1.13M vs. SHJBF: $4.5B
RGBP [@Biotechnology] is valued at $1.13M. SHJBF’s [@Biotechnology] market capitalization is $4.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RGBP’s FA Score shows that 1 FA rating(s) are green whileSHJBF’s FA Score has 0 green FA rating(s).

  • RGBP’s FA Score: 1 green, 4 red.
  • SHJBF’s FA Score: 0 green, 5 red.
According to our system of comparison, SHJBF is a better buy in the long-term than RGBP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RGBP’s TA Score shows that 1 TA indicator(s) are bullish.

  • RGBP’s TA Score: 1 bullish, 6 bearish.

Price Growth

RGBP (@Biotechnology) experienced а +11.37% price change this week, while SHJBF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.15%. For the same industry, the average monthly price growth was +33.42%, and the average quarterly price growth was +4.05%.

Reported Earning Dates

RGBP is expected to report earnings on May 16, 2025.

Industries' Descriptions

@Biotechnology (+7.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SHJBF($4.5B) has a higher market cap than RGBP($1.13M). SHJBF YTD gains are higher at: 0.000 vs. RGBP (-25.164). RGBP has higher annual earnings (EBITDA): -804.74K vs. SHJBF (-2.12B). SHJBF has more cash in the bank: 4.56B vs. RGBP (1.76K). RGBP has less debt than SHJBF: RGBP (968K) vs SHJBF (2.91B). SHJBF has higher revenues than RGBP: SHJBF (1.63B) vs RGBP (237K).
RGBPSHJBFRGBP / SHJBF
Capitalization1.13M4.5B0%
EBITDA-804.74K-2.12B0%
Gain YTD-25.1640.000-
P/E RatioN/AN/A-
Revenue237K1.63B0%
Total Cash1.76K4.56B0%
Total Debt968K2.91B0%
FUNDAMENTALS RATINGS
RGBP: Fundamental Ratings
RGBP
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RGBPSHJBF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
4%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
5%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
RGBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DSFRX38.420.17
+0.44%
Domini Impact Equity Y
ABLSX13.610.02
+0.15%
American Beacon Balanced Adv
VEMAX41.16N/A
N/A
Vanguard Emerging Mkts Stock Idx Adm
MYSIX18.69N/A
N/A
Victory Trivalent International Sm-Cp Y
TBDCX12.41N/A
N/A
PGIM Jennison Diversified Growth C

RGBP and

Correlation & Price change

A.I.dvisor tells us that RGBP and SABS have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RGBP and SABS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGBP
1D Price
Change %
RGBP100%
-2.03%
SABS - RGBP
23%
Poorly correlated
N/A
ASPHF - RGBP
8%
Poorly correlated
N/A
SHJBF - RGBP
8%
Poorly correlated
N/A
ROIV - RGBP
5%
Poorly correlated
+0.27%
AKESF - RGBP
4%
Poorly correlated
N/A
More

SHJBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SHJBF has been loosely correlated with ONWRF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SHJBF jumps, then ONWRF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHJBF
1D Price
Change %
SHJBF100%
N/A
ONWRF - SHJBF
42%
Loosely correlated
+4.03%
UCBJF - SHJBF
35%
Loosely correlated
N/A
OKYO - SHJBF
21%
Poorly correlated
+11.49%
PYXS - SHJBF
16%
Poorly correlated
+12.04%
INKT - SHJBF
10%
Poorly correlated
-2.31%
More